121 related articles for article (PubMed ID: 9193197)
1. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Gabriel SM; Haroutunian V; Powchik P; Honer WG; Davidson M; Davies P; Davis KL
Arch Gen Psychiatry; 1997 Jun; 54(6):559-66. PubMed ID: 9193197
[TBL] [Abstract][Full Text] [Related]
2. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia.
Honer WG; Falkai P; Young C; Wang T; Xie J; Bonner J; Hu L; Boulianne GL; Luo Z; Trimble WS
Neuroscience; 1997 May; 78(1):99-110. PubMed ID: 9135092
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
4. The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains.
Davidsson P; Gottfries J; Bogdanovic N; Ekman R; Karlsson I; Gottfries CG; Blennow K
Schizophr Res; 1999 Nov; 40(1):23-9. PubMed ID: 10541003
[TBL] [Abstract][Full Text] [Related]
5. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.
Shimohama S; Kamiya S; Taniguchi T; Akagawa K; Kimura J
Biochem Biophys Res Commun; 1997 Jul; 236(2):239-42. PubMed ID: 9240416
[TBL] [Abstract][Full Text] [Related]
7. Measurement of pre- and post-synaptic proteins in cerebral cortex: effects of post-mortem delay.
Siew LK; Love S; Dawbarn D; Wilcock GK; Allen SJ
J Neurosci Methods; 2004 Oct; 139(2):153-9. PubMed ID: 15488227
[TBL] [Abstract][Full Text] [Related]
8. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Oct; 54(10):943-52. PubMed ID: 9337775
[TBL] [Abstract][Full Text] [Related]
9. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.
Minger SL; Honer WG; Esiri MM; McDonald B; Keene J; Nicoll JA; Carter J; Hope T; Francis PT
J Neuropathol Exp Neurol; 2001 Oct; 60(10):929-36. PubMed ID: 11589423
[TBL] [Abstract][Full Text] [Related]
10. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia.
Narr KL; Toga AW; Szeszko P; Thompson PM; Woods RP; Robinson D; Sevy S; Wang Y; Schrock K; Bilder RM
Biol Psychiatry; 2005 Jul; 58(1):32-40. PubMed ID: 15992520
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of several proteins characteristic of nervous tissue in cerebral cortex of patients with Alzheimer's disease.
Kato K; Kurobe N; Suzuki F; Morishita R; Asano T; Sato T; Inagaki T
J Mol Neurosci; 1991; 3(2):95-9. PubMed ID: 1814396
[TBL] [Abstract][Full Text] [Related]
12. Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia.
Ramos-Miguel A; Beasley CL; Dwork AJ; Mann JJ; Rosoklija G; Barr AM; Honer WG
Biol Psychiatry; 2015 Sep; 78(6):361-73. PubMed ID: 25662103
[TBL] [Abstract][Full Text] [Related]
13. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.
Glantz LA; Lewis DA
Arch Gen Psychiatry; 1997 Jul; 54(7):660-9. PubMed ID: 9236550
[TBL] [Abstract][Full Text] [Related]
14. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.
Reddy PH; Mani G; Park BS; Jacques J; Murdoch G; Whetsell W; Kaye J; Manczak M
J Alzheimers Dis; 2005 Apr; 7(2):103-17; discussion 173-80. PubMed ID: 15851848
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.
Masliah E; Terry RD; DeTeresa RM; Hansen LA
Neurosci Lett; 1989 Aug; 103(2):234-9. PubMed ID: 2505201
[TBL] [Abstract][Full Text] [Related]
16. Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material.
Clinton J; Blackman SE; Royston MC; Roberts GW
Neuroreport; 1994 Jan; 5(4):497-500. PubMed ID: 8003683
[TBL] [Abstract][Full Text] [Related]
17. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
Osimo EF; Beck K; Reis Marques T; Howes OD
Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
[TBL] [Abstract][Full Text] [Related]
18. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia.
Perrone-Bizzozero NI; Sower AC; Bird ED; Benowitz LI; Ivins KJ; Neve RL
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14182-7. PubMed ID: 8943081
[TBL] [Abstract][Full Text] [Related]
19. Synaptophysin and chromogranin A immunoreactivities in senile plaques of Alzheimer's disease.
Brion JP; Couck AM; Bruce M; Anderton B; Flament-Durand J
Brain Res; 1991 Jan; 539(1):143-50. PubMed ID: 1901750
[TBL] [Abstract][Full Text] [Related]
20. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
Egbujo CN; Sinclair D; Borgmann-Winter KE; Arnold SE; Turetsky BI; Hahn CG
Schizophr Res; 2015 Oct; 168(1-2):554-62. PubMed ID: 26260078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
